# Jonas Oldgren

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jonas-oldgren/

## Facts

| Field | Value |
| --- | --- |
| Citations | 54,585 |
| Field | Atrial Fibrillation Management and Outcomes |
| h-index | 68 |
| i10-index | 167 |
| Last Known Institution | Uppsala University |
| OpenAlex ID | https://openalex.org/A5081852908 |
| ORCID iD | https://orcid.org/0000-0002-9969-3921 |
| Works | 305 |

## Researcher papers

Showing 12 of 13.

- [Dabigatran versus Warfarin in Patients with Atrial Fibrillation](https://scholariq.org/papers/dabigatran-versus-warfarin-in-patients-with-atrial-fibrillation/)
- [2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS](https://scholariq.org/papers/2016-esc-guidelines-for-the-management-of-atrial-fibrillation-developed-in/)
- [2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS](https://scholariq.org/papers/2016-esc-guidelines-for-the-management-of-atrial-fibrillation-developed-in-5/)
- [2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)](https://scholariq.org/papers/2024-esc-guidelines-for-the-management-of-atrial-fibrillation-developed-in/)
- [The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation](https://scholariq.org/papers/the-2018-european-heart-rhythm-association-practical-guide-on-the-use-of-non/)
- [2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS](https://scholariq.org/papers/2016-esc-guidelines-for-the-management-of-atrial-fibrillation-developed-in-4/)
- [2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS](https://scholariq.org/papers/2016-esc-guidelines-for-the-management-of-atrial-fibrillation-developed-in-2/)
- [Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation](https://scholariq.org/papers/dual-antithrombotic-therapy-with-dabigatran-after-pci-in-atrial-fibrillation/)
- [2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation](https://scholariq.org/papers/2021-european-heart-rhythm-association-practical-guide-on-the-use-of-non-vitamin/)
- [The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study](https://scholariq.org/papers/the-novel-biomarker-based-abc-age-biomarkers-clinical-history-bleeding-risk/)
- [2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS](https://scholariq.org/papers/2016-esc-guidelines-for-the-management-of-atrial-fibrillation-developed-in-3/)
- [Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study](https://scholariq.org/papers/safety-of-the-oral-factor-xia-inhibitor-asundexian-compared-with-apixaban-in/)

## Researcher topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Cardiac Arrhythmias and Treatments](https://scholariq.org/topics/cardiac-arrhythmias-and-treatments/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management-2/)

## Researcher university

- [Uppsala University](https://scholariq.org/institutions/uppsala-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.